FDA Inspection
Suzanne K. Gazda, M.D.Suzanne K. Gazda, M.D. – FDA Inspection, Dec 8, 2011
Record Details
This FDA Inspection record concerns Suzanne K. Gazda, M.D., with an inspection on December 8, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Suzanne K. Gazda, M.D.
- Inspection Date
- December 8, 2011
- Product Type
- Drugs
View Company Profile
ID · f68b9d9e-e41e-4a49-a214-a3ce6b89e989
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 763280
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Unanticipated problems
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Suzanne K. Gazda, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 3, 2008 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Suzanne K. Gazda, M.D.
- FDA Inspection 958697 - 2016-02-11
- FDA Inspection 551793 - 2008-12-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.